Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600422)"KPC PHARMACEUTICALS, INC."Report for Q3 2026
Filed with SSE · Stock code 600422 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)KPC Pharmaceuticals, Inc. on 6ix
Earlier from KPC Pharmaceuticals
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Receipt of the Notice of Registration Acceptance from the National Association of Financial Market Institutional Investors
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Amendments to the Articles of Association
- Announcement on Resolutions of the 21st Meeting of the 11th Board of Directors
Follow KPC Pharmaceuticals into a list and get an email when it puts out news.
Follow KPC Pharmaceuticals